Copyright © Inderes 2011 - present. All rights reserved.

Prostatype Genomics

0.56 SEK

-1.06 %

Less than 1K followers

PROGEN

First North Stockholm

Medical Equipment & Services

Health Care

-1.06 %
-3.10 %
-1.40 %
-53.74 %
-90.66 %
-87.43 %
-99.45 %
-99.89 %
-99.85 %

Prostatype Genomics operates in the medical technology sector. The company specializes in the development of medical genetic tests used for the identification, analysis and further follow-up of prostate cancer. In addition to its main business, related ancillary services are also offered. The business is operated globally with the largest presence in the Nordic market. The head office is located in Nacka Strand.

Read more
Market cap
33.26M SEK
Turnover
49.01K SEK
Revenue
200K
EBIT %
-20,425 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
12/2
2026

Annual report '25

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.